| Literature DB >> 32227665 |
Simon Boussion1,2, Fabienne Escande2,3, Anne-Sophie Jourdain2,3, Thomas Smol2,4, Perrine Brunelle2,3, Céline Duhamel2, Yves Alembik5, Tania Attié-Bitach6, Geneviève Baujat7, Anne Bazin8, Maryse Bonnière6, Philippe Carassou9, Dominique Carles10, Louise Devisme2,11, Cyril Goizet12, Alice Goldenberg13, Sarah Grotto14, Agnès Guichet15, Pierre-Simon Jouk16, Laurence Loeuillet17, Charlotte Mechler18, Caroline Michot7, Fanny Pelluard19, Audrey Putoux20,21, Sandra Whalen22, Jamal Ghoumid1,2, Sylvie Manouvrier-Hanu1,2, Florence Petit1,2.
Abstract
Thrombocytopenia-absent radius (TAR) syndrome is characterized by radial defect and neonatal thrombocytopenia. It is caused by biallelic variants of RBM8A gene (1q21.1) with the association of a null allele and a hypomorphic noncoding variant. RBM8A encodes Y14, a core protein of the exon junction complex involved in messenger RNA maturation. To date, only two hypomorphic variants have been identified. We report on a cohort of 26 patients affected with TAR syndrome and carrying biallelic variants in RBM8A. Half patients carried a 1q21.1 deletion and one of the two known hypomorphic variants. Four novel noncoding variants of RBM8A were identified in the remaining patients. We developed experimental models enabling their functional characterization in vitro. Two variants, located respectively in the 5'-untranslated region (5'-UTR) and 3'-UTR regions, are responsible for a diminished expression whereas two intronic variants alter splicing. Our results bring new insights into the molecular knowledge of TAR syndrome and enabled us to propose genetic counseling for patients' families.Entities:
Keywords: RBM8A; TAR syndrome; Y14; exon junction complex; regulatory SNP
Year: 2020 PMID: 32227665 DOI: 10.1002/humu.24021
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878